Dow Down0.25% Nasdaq Down0.14%

Celldex Therapeutics, Inc. (CLDX)

-NMS
13.69 0.66(4.60%) Sep 29, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (81,550) (59,123) (44,799)
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,579  2,477  4,178  
Adjustments To Net Income4,624  2,444  2,596  
Changes In Accounts Receivables(445)126  154  
Changes In Liabilities8,553  4,356  1,938  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(430)(62)275  
Total Cash Flow From Operating Activities (67,669) (49,782) (35,658)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,219)(303)(509)
Investments(73,224)(16,895)(1,714)
Other Cash flows from Investing Activities21  218  68  
Total Cash Flows From Investing Activities (77,422) (16,980) (2,155)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock301,100  83,784  36,023  
Net Borrowings(11,029)(3,971)(7,503)
Other Cash Flows from Financing Activities(472)(55)(86)
Total Cash Flows From Financing Activities 289,599   79,758   28,434  
Effect Of Exchange Rate Changes(3)2  (9)
Change In Cash and Cash Equivalents 144,505   12,998   (9,388)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.